Cited by 245Cardiac Fibrosis and RemodelingCardiovascular Function and Risk FactorsCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload

Hu, Ping, Zhang, Dongfang, Swenson, LeAnne, Chakrabarti, Gopa, Abel, E. Dale, Litwin, Sheldon E.·2003·American Journal of Physiology-Heart and Circulatory Physiology

DOI 10.1152/ajpheart.00108.2003

Open this paper in CoChat — free account

Abstract

We developed a minimally invasive method for producing left ventricular (LV) pressure overload in mice. With the use of this technique, we quickly and reproducibly banded the transverse aorta with low surgical morbidity and mortality. Minimally invasive transverse aortic banding (MTAB) acutely and chronically increased LV systolic pressure, increased heart weight-to-body weight ratio, and induced myocardial fibrosis. We used this technique to determine whether reduced insulin signaling in the heart altered the cardiac response to pressure overload. Mice with cardiac myocyte-restricted knockout of the insulin receptor (CIRKO) have smaller hearts than wild-type (WT) controls. Four weeks after MTAB, WT and CIRKO mice had comparably increased LV systolic pressure, increased cardiac mass, and induction of mRNA for β-myosin heavy chain and atrial natriuretic factor. However, CIRKO hearts were more dilated, had depressed LV systolic function by echocardiography, and had greater interstitial fibrosis than WT mice. Expression of connective tissue growth factor was increased in banded CIRKO hearts compared with WT hearts. Thus lack of insulin signaling in the heart accelerates the transition to a more decompensated state during cardiac pressure overload. The use of the MTAB approach should facilitate the study of the pathophysiology and treatment of pressure-overload hypertrophy.

Integrity signals

Registry

Crossref · 10.1152/ajpheart.00108.2003

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 807
Retracted
Hypertension and associated metabolic abnormalities–the role of insulin resistance and the sympathoadrenal system.
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Impact of Diabetes on Cardiac Structure and Function
Devereux, R. B., Roman, M. J., Paranicas, M., O’Grady, M. J., Lee, E. T., Welty, T. K., Fabsitz, R. R., Robbins, D. C., Rhoades, E. R., & Howard, B. V. (2000) · Circulation · doi:10.1161/01.cir.101.19.2271 · Cited by 943
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F., Windt, L. J. D., Tymitz, K. M., Witt, S. A., Kimball, T. R., Klevitsky, R., Hewett, T. E., Jones, S. P., Lefer, D. J., Peng, C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 684
The conserved phosphoinositide 3‐kinase pathway determines heart size in mice
Shioi, T., Kang, P., Douglas, P., Hampe, J., Yballe, C., Lawitts, J., Cantley, L., & Izumo, S. (2000) · EMBO Journal · doi:10.1093/emboj/19.11.2537 · Cited by 646
Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts
Allard, M., Schönekess, B. O., Henning, S. L., English, D. R., & Lopaschuk, G. D. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.2.h742 · Cited by 576
Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways
Crackower, M. A., Oudit, G. Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., Irie-Sasaki, J., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00969-8 · Cited by 576

Show all 44 references

Sorted by citations

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
Shiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 935
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 888
Cardiac remodeling in obesity
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Self-citation
Diabetic Cardiomyopathy
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 567
Reduced Cardiac Efficiency and Altered Substrate Metabolism Precedes the Onset of Hyperglycemia and Contractile Dysfunction in Two Mouse Models of Insulin Resistance and Obesity
Buchanan, J., Mazumder, P. K., Hu, P., Chakrabarti, G., Roberts, M. W., Yun, U. J., Cooksey, R. C., Litwin, S. E., & Abel, E. D. (2005) · Endocrinology · doi:10.1210/en.2005-0938 · Cited by 555
Self-citation
Molecular basis of physiological heart growth: fundamental concepts and new players
Maillet, M., van Berlo, J. H., & Molkentin, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3495 · Cited by 536
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
Oudit, G. Y. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 467
Insulin Signaling and Heart Failure
Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 420
Self-citation
BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathwayPreprint
Shiojima, I., & Walsh, K. X. (2006) · Genes & Development · doi:10.1101/gad.1492806 · Cited by 357
Insulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 356
Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload
Izumiya, Y., Shiojima, I., Sato, K., Sawyer, D. B., Colucci, W. S., & Walsh, K. X. (2006) · Hypertension · doi:10.1161/01.hyp.0000215207.54689.31 · Cited by 324
Differential Cardiac Remodeling in Preload Versus Afterload
Toischer, K., Rokita, A. G., Unsöld, B. W., Zhu, W., Kararigas, G., Sossalla, S. T., Reuter, S. P., Becker, A., Teucher, N., Seidler, T., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.943431 · Cited by 322
Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies
Tarnavski, O., McMullen, J. R., Schinke, M., Nie, Q. H., Kong, S. W., & Izumo, S. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2003 · Cited by 318
Glucose metabolism and cardiac hypertrophy
Kolwicz, S. C., & Tian, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr071 · Cited by 302
Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart
Boudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.792101 · Cited by 301
Self-citation
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats
Ouwens, D. M., Boer, C., Fodor, M., de Galan, P., Heine, R. J., Maassen, J. A., & Diamant, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1755-x · Cited by 256
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
Gélinas, R., Mailleux, F., Dontaine, J., Bultot, L., Demeulder, B., Ginion, A., Daskalopoulos, E. P., Esfahani, H., Dubois‐Deruy, E., Lauzier, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02795-4 · Cited by 261
A Drosophila Model of High Sugar Diet-Induced Cardiomyopathy
Na, J., Musselman, L. P., Pendse, J., Baranski, T., Bodmer, R., Ocorr, K. A., & Cagan, R. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003175 · Cited by 252
Mouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 251
Mouse Models of Insulin Resistance
Nandi, A. A., KITAMURA, Y., Kahn, C. R., & Accili, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 249
Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart
Abel, E. D., O’Shea, K. M., & Ramasamy, R. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241984 · Cited by 253
Self-citation
Vascular PPARγ Controls Circadian Variation in Blood Pressure and Heart Rate through Bmal1
Wang, N., Yang, G., Jia, Z., Zhang, H. E., Aoyagi, T., Soodvilai, S., Symons, J. D., Schnermann, J. B., Gonzalez, F. J., Litwin, S. E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.009 · Cited by 238
Self-citation
Small animal models of heart failure
Riehle, C., & Bauersachs, J. K. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz161 · Cited by 236
Protective Factors and the Pathogenesis of Complications in Diabetes
Yu, M. G., Gordin, D., Fu, J., Park, K., Li, Q., & King, G. L. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad030 · Cited by 252
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
Hsueh, W. A., Abel, E. D., Breslow, J. L., Maeda, N., Davis, R. C., Fisher, E. A. A., Dansky, H. M., McClain, D. A., McIndoe, R., Wassef, M. K., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000266449.37396.1f · Cited by 221
Self-citation
Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis
Sugden, P. H., Fuller, S. J., Weiss, S. C., & Clerk, A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707659 · Cited by 218
Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents
Shimizu, I., Minamino, T., Toko, H., Okada, S., Ikeda, H., Yasuda, N., Tateno, K., Moriya, J., Yokoyama, M., Nojima, A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40096 · Cited by 218
Self-citation
PGC-1α Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress After Chronic Systolic Overload
Lu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., Li, J., Huang, Y., Zhang, P., Zhao, B., et al. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2940 · Cited by 215
Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload
Meyer, A., Wang, W., Qu, J., Croft, L. B., Degen, J. L., Coller, B. S., & Ahamed, J. (2011) · Blood · doi:10.1182/blood-2011-09-377648 · Cited by 204
Long noncoding RNA dysregulation in ischemic heart failure
Greco, S., Zaccagnini, G., Perfetti, A., Fuschi, P., Valaperta, R., Voellenkle, C., Castelvecchio, S., Gaetano, C., Finato, N., Beltrami, A. P., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0926-5 · Cited by 202
Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
Bugger, H., & Abel, E. D. (2008) · Clinical Science · doi:10.1042/cs20070166 · Cited by 197
Self-citation
AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
Zhang, P., Hu, X., Xu, X. Y., Fassett, J., Zhu, G., Viollet, B., Xu, W. W., Wiczer, B. M., Bernlohr, D., Bache, R. J., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114702 · Cited by 190
Muscle Ring Finger 1, but not Muscle Ring Finger 2, Regulates Cardiac Hypertrophy In Vivo
Willis, M. S., Ike, C., Li, L., Wang, D.-Z., Glass, D. J., & Patterson, C. (2007) · Circulation Research · doi:10.1161/01.res.0000259559.48597.32 · Cited by 173
Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart
Lu, Z., Xu, X. Y., Hu, X., Lee, S.-J., Traverse, J. H., Zhu, G., Fassett, J. T., Tao, Y., Zhang, P., dos Remedios, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.906818 · Cited by 168
The Ca V 3.2 T-Type Ca 2+ Channel Is Required for Pressure Overload–Induced Cardiac Hypertrophy in Mice
Chiang, C.-S., Huang, C., Chieng, H., Chang, Y.-T., Chang, D., Chen, J.-J., Chen, Y.-C., Chen, Y., Shin, H., Campbell, K. P., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.184051 · Cited by 157
PGC-1β Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy
Riehle, C., Wende, A. R., Zaha, V. G., Pires, K. M. P., Wayment, B. E., Olsen, C. D., Bugger, H., Buchanan, J., Wang, X., Moreira, A. B., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243964 · Cited by 159
Self-citation
Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart Failure
Zhang, P., Xu, X., Hu, X., van Deel, E. D., Zhu, G., & Chen, Y. (2007) · Circulation Research · doi:10.1161/01.res.0000264081.78659.45 · Cited by 152
Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload
Zhabyeyev, P., Gandhi, M., Mori, J., Basu, R., Kassiri, Z., Clanachan, A. S., Lopaschuk, G. D., & Oudit, G. Y. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs424 · Cited by 151
Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice
Richards, D. A., Aronovitz, M. J., Calamaras, T. D., Tam, K., Martin, G., Liu, P., Bowditch, H. K., Zhang, P., Huggins, G. S., & Blanton, R. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42209-7 · Cited by 146
Endothelial p53 Deletion Improves Angiogenesis and Prevents Cardiac Fibrosis and Heart Failure Induced by Pressure Overload in Mice
Gogiraju, R., Xu, X., Bochenek, M. L., Steinbrecher, J. H., Lehnart, S. E., Wenzel, P., Kessel, M., Zeisberg, E. M., Dobbelstein, M., & Schäfer, K. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001770 · Cited by 144
1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload
O’Connell, T. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 143
Akt1 in the cardiovascular system: friend or foe?
O'Neill, B. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25900 · Cited by 141
Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy
Barrick, C. J., Rojas, M., Schoonhoven, R., Smyth, S. S., & Threadgill, D. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00816.2006 · Cited by 136
Cardiac Dysfunction and Oxidative Stress in the Metabolic Syndrome: an Update on Antioxidant Therapies
Ilkun, O. L., & Boudina, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270003 · Cited by 138
In vivo model with targeted cAMP biosensor reveals changes in receptor–microdomain communication in cardiac disease
Sprenger, J., Perera, R. K., Steinbrecher, J. H., Lehnart, S. E., Maier, L. S., Hasenfuss, G. P., & Nikolaev, V. O. (2015) · Nature Communications · doi:10.1038/ncomms7965 · Cited by 131
Fuel availability and fate in cardiac metabolism: a tale of two substrates
Pascual, F., & Coleman, R. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.014 · Cited by 125
Echocardiographic assessment of global left ventricular function in mice
Stypmann, J., Engelen, M. A., Troatz, C., Rothenburger, M., Eckardt, L., & Tiemann, K. (2009) · Laboratory Animals · doi:10.1258/la.2007.06001e · Cited by 125
Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction
Methawasin, M., Strom, J. G., Slater, R. E., Fernandez, V., Saripalli, C., & Granzier, H. L. M. (2016) · Circulation · doi:10.1161/circulationaha.116.023003 · Cited by 120
Mechanisms of Lipotoxicity in the Cardiovascular System
Wende, A. R., Symons, J. D., & Abel, E. D. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0307-2 · Cited by 110
Self-citation
FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model
Schips, T. G., Wietelmann, A., Höhn, K., Schimanski, S., Walther, P., Braun, T. W., Wirth, T., & Maier, H. J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr144 · Cited by 118
Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload–Induced Left Ventricular Hypertrophy and Dysfunction
Lu, Z., Xu, X., Hu, X., Zhu, G., Zhang, P., van Deel, E. D., French, J. P., Fassett, J. T., Oury, T. D., Bache, R. J., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098186 · Cited by 113
Myocyte-Restricted Focal Adhesion Kinase Deletion Attenuates Pressure Overload–Induced Hypertrophy
DiMichele, L. A., Doherty, J. T., Rojas, M., Beggs, H. E., Reichardt, L. F., Mack, C. P., & Taylor, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000240498.44752.d6 · Cited by 102
Physiological myocardial hypertrophy: how and why?
Catalucci, D. (2007) · Frontiers in bioscience · doi:10.2741/2681 · Cited by 94
Insulin signaling in the heart
Abel, E. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2021 · Cited by 94
Self-citation
The class IA phosphatidylinositol 3-kinase p110-β subunit is a positive regulator of autophagy
Dou, Z., Chattopadhyay, M., Pan, J.-A., Guerriero, J. L., Jiang, Y.-P., Ballou, L. M., Yue, Z., Lin, R. Z., & Zong, W. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201006056 · Cited by 93
IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice
Yu, Q., Vazquez, R., Khojeini, E. V., Patel, C. A., Venkataramani, R., & Larson, D. F. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01285.2008 · Cited by 90
Rodent models of heart failure: an updated review
Pinho‐Gomes, A., Falcão‐Pires, I., Pires, A. L. R., Brás‐Silva, C., & Leite-Moreira, A. F. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9305-3 · Cited by 89
Variable phenotype in murine transverse aortic constriction
Mohammed, S. F., Storlie, J. R., Oehler, E. A., Bowen, L. A., Korinek, J. K., Lam, C. S. P., Simari, R. D., Burnett, J. C. J., & Redfield, M. M. (2011) · Cardiovascular Pathology · doi:10.1016/j.carpath.2011.05.002 · Cited by 88
Mineralocorticoid Accelerates Transition to Heart Failure With Preserved Ejection Fraction Via “Nongenomic Effects”
Mohammed, S. F., Ohtani, T., Korinek, J. K., Lam, C. S. P., Larsen, K., Simari, R. D., Valencik, M. L., Burnett, J. C. J., & Redfield, M. M. (2010) · Circulation · doi:10.1161/circulationaha.109.915215 · Cited by 86
Xanthine Oxidase Inhibition With Febuxostat Attenuates Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
Xu, X. Y., Hu, X., Lu, Z., Zhang, P., Zhao, L., Wessale, J. L., Bache, R. J., & Chen, Y. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.006 · Cited by 81
Transgenic Mice for Real-Time Visualization of cGMP in Intact Adult Cardiomyocytes
Götz, K. R., Sprenger, J., Perera, R. K., Steinbrecher, J. H., Lehnart, S. E., Kühn, M., Gorelik, J., Balligand, J., & Nikolaev, V. O. (2014) · Circulation Research · doi:10.1161/circresaha.114.302437 · Cited by 79
REV-ERBα ameliorates heart failure through transcription repression.
Zhang, L.-L., Zhang, R., Tien, C.-L., Chan, R., Sugi, K., Fu, C., Griffin, A. C., Shen, Y.-Y., Burris, T., Liao, X., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95177 · Cited by 72
Metformin Protects Against Systolic Overload–Induced Heart Failure Independent of AMP-Activated Protein Kinase α2
Xu, X. Y., Lu, Z., Fassett, J., Zhang, P., Hu, X., Liu, X., Kwak, D., Li, J., Zhu, G., Tao, Y., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02619 · Cited by 79
G i -Biased β 2 AR Signaling Links GRK2 Upregulation to Heart Failure
Zhu, W., Petrashevskaya, N. N., Ren, S. V., Zhao, A., Chakir, K., Gao, E., Chuprun, J. K., Wang, Y., Talan, M. I., Dorn, G. W., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.253260 · Cited by 77
Diabetes-Related Heart Failure
Bando, Y., & Murohara, T. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1564 · Cited by 74
Insulin stimulates Akt translocation to mitochondria: Implications on dysregulation of mitochondrial oxidative phosphorylation in diabetic myocardium
Yang, J., Yeh, H.-Y., Lin, K., & Wang, P. H. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.015 · Cited by 68
Mouse Models of Heart Failure with Preserved or Reduced Ejection Fraction
Noll, N. A., Lal, H., & Merryman, W. D. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.04.006 · Cited by 67
BAMBI (BMP and activin membrane-bound inhibitor) protects the murine heart from pressure-overload biomechanical stress by restraining TGF-β signaling
Villar, A. V., García, R., Llano, M., Cobo, M., Merino, D., Lantero, A., Tramullas, M., Hurlé, J. M., Hurlé, M. A., & Nistal, J. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.007 · Cited by 66
Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction
Sena, S., Hu, P., Zhang, D., Wang, X., Wayment, B. E., Olsen, C. D., Avelar, E., Abel, E. D., & Litwin, S. E. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.014 · Cited by 68
Self-citation
Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling
Zhang, M., Mongue‐Din, H., Martin, D., Catibog, N., Smyrnias, I., Zhang, X., Yu, B., Wang, M., Brandes, R. P., Schröder, K., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx204 · Cited by 67
Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure
Heron, C., Dumesnil, A., Houssari, M., Renet, S., Lemarcis, T., Lebon, A., Godefroy, D., Schapman, D., Henri, O., Riou, G., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac086 · Cited by 66
Animal models of insulin resistance and heart failure
Velez, M., Kohli, S., & Sabbah, H. N. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9387-6 · Cited by 66
How cardiomyocytes sense pathophysiological stresses for cardiac remodeling
Haque, Z. K., & Wang, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2373-0 · Cited by 64
Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses
Wende, A. R., Kim, J., Holland, W. L., Wayment, B. E., O'Neill, B. T., Tuinei, J., Brahma, M. K., Pepin, M. E., McCrory, M. A., Luptak, I., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00101.2017 · Cited by 65
Self-citation
A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice
Melleby, A. O., Romaine, A., Aronsen, J. M., Veras, I., Zhang, L., Sjaastad, I., Lunde, I. G., & Christensen, G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy141 · Cited by 64
Genetic loss of insulin receptors worsens cardiac efficiency in diabetes
Bugger, H., Riehle, C., Jaishy, B. P., Wende, A. R., Tuinei, J., Chen, D., Soto, J. E., Pires, K. M. P., Boudina, S., Theobald, H. A., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.001 · Cited by 64
Self-citation
Hemoglobin S-nitrosylation plays an essential role in cardioprotection
Zhang, R., Hess, D. T., Reynolds, J. D., & Stamler, J. S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90425 · Cited by 62
Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density
McQueen, A. P., Zhang, D., Hu, P., Swenson, L., Yang, Y., Zaha, V. G., Hoffman, J. L., Yun, U. J., Chakrabarti, G., & Wang, Z. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.07.017 · Cited by 61
Self-citation
Animal Models of Myocardial and Vascular Injury
Abarbanell, A. M., Herrmann, J. L., Weil, B. R., Wang, Y., Tan, J., Moberly, S. P., Fiege, J. W., & Meldrum, D. R. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.06.021 · Cited by 61
Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy
Tang, Y., Feng, M., Su, Y., Ma, T., Zhang, H., Wu, H., Wang, X., Shi, S., Zhang, Y., Xu, Y., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064121 · Cited by 60
The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet
Chess, D. J., Xu, W., Khairallah, R. J., O’Shea, K. M., Kop, W. J., Azimzadeh, A. M., & Stanley, W. C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00563.2008 · Cited by 58
Androgens Contribute to Sex Differences in Myocardial Remodeling under Pressure Overload by a Mechanism Involving TGF-β
Montalvo, C., Villar, A. V., Merino, D., García, R., Ares, M., Llano, M., Cobo, M., Hurlé, M. A., & Nistal, J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035635 · Cited by 59
Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice
Steinbusch, L. K. M., Luiken, J. J. F. P., Vlasblom, R., Chabowski, A., Hoebers, N., Coumans, W. A., Vroegrijk, I. O. C. M., Voshol, P. J., Ouwens, D. M., Glatz, J. F. C., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00106.2011 · Cited by 57
A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload
Chess, D. J., Khairallah, R. J., O’Shea, K. M., Xu, W., & Stanley, W. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00599.2009 · Cited by 58
cAMP Imaging at Ryanodine Receptors Reveals β 2 -Adrenoceptor Driven Arrhythmias
Berisha, F., Götz, K. R., Wegener, J. W., Brandenburg, S., Subramanian, H., Molina, C. E., Rüffer, A., Petersen, J., Bernhardt, A. M. J., Girdauskas, E., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318234 · Cited by 56
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B
Gomez, É., Vercauteren, M., Kurtz, B., Ouvrard‐Pascaud, A., Mulder, P. G. H., Henry, J., Besnier, M., Waget, A., van Huijsduijnen, R. H., Tremblay, M. L., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.003 · Cited by 56
Insulin signaling in heart muscle: Lessons from genetically engineered mouse models
Abel, E. D. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0034-4 · Cited by 54
Self-citation
AMPK attenuates microtubule proliferation in cardiac hypertrophy
Fassett, J., Hu, X., Xu, X. Y., Lu, Z., Zhang, P., Chen, Y., & Bache, R. J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00935.2011 · Cited by 55
Activating Transcription Factor 3 Protects against Pressure-Overload Heart Failure via the Autophagy Molecule Beclin-1 Pathway
Lin, H., Li, H.-F., Chen, H.-H., Lai, P., Juan, S., Chen, J., & Cheng, C. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.090092 · Cited by 52
VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation
Xu, X., Xu, J., Xue, L., Cao, H. L., Liu, X., & Chen, Y. J. (2011) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-6-54 · Cited by 52
Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy
Guo, J., Mihic, A., Wu, J., Zhang, Y., Singh, K., Dhingra, S., Weisel, R. D., & Li, R. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv294 · Cited by 51
Induction of heart failure by minimally invasive aortic constriction in mice: Reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction
Färber, G., Barreto, F., Schoepe, M., Gilsbach, R., Schrepper, A., Schwarzer, M., Mohr, F. W., Hein, L., & Doenst, T. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.03.029 · Cited by 50
Insulin resistance in obesity: pathogenesis and effects
Lavrenova, Е. A., & Drapkina, O. M. (2020) · Obesity and metabolism · doi:10.14341/omet9759 · Cited by 48
Merits of Non-Invasive Rat Models of Left Ventricular Heart Failure
Carll, A. P., Willis, M. S., Lust, R. M., Costa, D. L. D. C., & Farraj, A. K. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9103-5 · Cited by 49
Preserved cerebral microcirculation during cardiogenic shock*
Wan, Z., Ristagno, G., Sun, S., Li, Y., Weil, M. H., & Tang, W. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a3a97b · Cited by 48
Minimally Invasive Transverse Aortic Constriction in Mice
Zaw, A. M., Williams, C. M., Law, H., & Chow, B. (2017) · Journal of Visualized Experiments · doi:10.3791/55293 · Cited by 47
Microtubule Actin Cross-Linking Factor 1 Regulates Cardiomyocyte Microtubule Distribution and Adaptation to Hemodynamic Overload
Fassett, J. T., Xu, X. Y., Kwak, D., Wang, H., Liu, X., Hu, X., Bache, R. J., & Chen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073887 · Cited by 46
The Pathophysiology of Cardiac Hypertrophy and Heart Failure
Stansfield, W. E., Ranek, M. J., Pendse, A. A., Schisler, J. C., Wang, S., Pulinilkunnil, T., & Willis, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405206-2.00004-1 · Cited by 46
Transient Expression of FRNK Reveals Stage-Specific Requirement for Focal Adhesion Kinase Activity in Cardiac Growth
DiMichele, L. A., Hakim, Z. S., Sayers, R. L., Rojas, M., Schwartz, R. J., Mack, C. P., & Taylor, J. M. (2009) · Circulation Research · doi:10.1161/circresaha.109.195941 · Cited by 45

Authors: Hu, P., Zhang, D., Swenson, L., Chakrabarti, G., Abel, E. D., & Litwin, S. E.
Affiliations: University of Utah (US)
ORCID: Zhang, Dongfang
Abel, E. Dale
Litwin, Sheldon E.
Venue: American Journal of Physiology-Heart and Circulatory Physiology
Publisher: American Physiological Society
Published: 2003-09
Volume: 285
Issue: 3
Pages: H1261-H1269
ISSN: 0363-6135 (ISSN-L)
1522-1539
DOI: 10.1152/ajpheart.00108.2003
OpenAlex: W2153616813
Cited by: 245
References: 44
Citations by year: 2026: 6 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 14 · 2016: 10 · 2015: 16 · 2014: 10 · 2013: 17 · 2012: 16
FWCI: 4.39
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Heart and Circulatory Physiology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r03dk058073-03)
U.S. Public Health Service (U01-70525)
National Heart, Lung, and Blood Institute (T32-HL-7576, HL-52338-06, P50HL052338, T32HL007576)
National Institute of Diabetes and Digestive and Kidney Diseases (DK58073, R01DK092065)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: left ventricular pressure overload, cardiac hypertrophy, myocardial fibrosis, connective tissue growth factor, beta-myosin heavy chain, atrial natriuretic peptide, cardiac remodeling, heart failure
MeSH terms: Animals, Aorta, Blood Pressure, Disease Models, Animal, Fibrosis, Insulin, Male, Mice, Inbred C57BL, Myocardial Contraction, Signal Transduction, Hypertrophy, Left Ventricular, Ventricular Pressure, Myocytes, Cardiac, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks